NCT02445391
Clinical Trial Information
Trial Number: NCT02445391 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
A Randomized Phase III Post-operative Trial of Platinum Based Chemotherapy vs. Capecitabine in Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Study ID:
EA1131
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT02445391-D3 | There are three submissions for PMID 34092112. This dataset, NCT02445391-D3, contains toxicity data. Dataset NCT02445391-D1 contains baseline, treatment, and efficacy data. Dataset NCT02445391-D2 contains data on dose modification. |
| NCT02445391-D2 | There are three submissions for PMID 34092112. This dataset, NCT02445391-D2 contains data on dose modification. Dataset NCT02445391-D1 contains baseline, treatment, and efficacy data. Dataset NCT02445391-D3 contains toxicity data. |
| NCT02445391-D1 | There are three submissions for PMID 34092112. This dataset, NCT02445391-D1, contains baseline, treatment, and efficacy data. Dataset NCT02445391-D2 contains data on dose modification. Dataset NCT02445391-D3 contains toxicity data. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®